Physician
Morris, Madeline
Morris, Madeline was paid $102K by Medicaid between Mar 2018 and Mar 2023, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 61% of everything it billed.
33Billing provider infoMORRIS, MADELINE
AUBURN, MA 01501
AUBURN, MA 01501
33aNPI1306920079assigned 10/25/2006
33bProvider typePediatrics Physician
28Total paid$102K
24GClaims2,892
24DCodes billed12
24AFirst – last monthMar 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#398 of 1,273
Median peer was paid$24K
This provider vs. median4.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 659 | $21K | |
| 2019 | 661 | $23K | |
| 2020 | 470 | $17K | |
| 2021 | 538 | $19K | |
| 2022 | 520 | $19K | |
| 2023 | 44 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 61% | 1,080 | 1,055 | $62K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 374 | 307 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.0% | 179 | 178 | $9K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.1% | 166 | 165 | $5K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 4.7% | 533 | 533 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 31 | 31 | $2K |
| 96127 | 1.6% | 150 | 148 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.5% | 47 | 45 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.4% | 132 | 130 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 62 | 62 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 81 | 81 | $956.61 |
| 87081 | <1% | 57 | 57 | $389.88 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.